Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0006-2952(88)90326-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.
Drug Metab Pharmacokinet
October 2006
Laboratory of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Chiba Institute of Science, Choshi, Chiba, Japan.
Troglitazone (TGZ), a thiazolidinedione class of antidiabetic agent, causes serious idiosyncratic hepatotoxicity. TGZ is metabolized into reactive metabolites that covalently bind to cellular macromolecules, one of which is oxidation at the chromane ring, a unique structure of TGZ, and another involves oxidative cleavage of the thiazolidinedione ring, a structure common to less hepatotoxic antidiabetics, rosiglitazone and pioglitazone. TGZ is cytotoxic to HepG2 cells and rat and human hepatocytes.
View Article and Find Full Text PDFNon-metabolic covalent binding of nicotine-delta 1'(5')-iminium ion to liver microsomes and sulfhydryl-containing polyamino acids.
Biochem Pharmacol
December 1988
Department of Biochemistry, Brandeis University, Waltham, MA 02254.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!